Skip to main content
Log in

Intermediate clinical events, surrogate markers and survival

  • Published:
Lifetime Data Analysis Aims and scope Submit manuscript

Abstract

This paper investigates one- and two-sample problems comparing survival times when an individual may experience an intermediate event prior to death or reaching some well defined endpoint. The intermediate event may be polychotomous. Patients experiencing the intermediate event may have an altered survival distribution after the intermediate event. Score tests are derived for testing if the occurrence of the intermediate event actually alters survival. These models have implications for evaluating therapies without randomization as well as strengthening the log rank test for comparing two survival distributions. The exact distribution of the score tests can be found by conditioning on both the waiting time and occurrence of the intermedate event.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • A. Agresti,Categorical Data Analysis, Wiley: New York, 1990.

    Google Scholar 

  • M. Aitken, N. Laird, and B. Francis, “A reanalysis of the Stanford heart transplant data,”J. Am. Stat. Assoc. vol. 78 pp. 264–274, 1983.

    Google Scholar 

  • P. K. Andersen, “Time dependent covariates and Markov processes,”Modern Statistical Methods in Chronic Disease Epidemiology (S. Moolgavkar and R. L. Prentice RL, eds.), New York: Wiley, 1986, pp. 82–103.

    Google Scholar 

  • P. K. Andersen and R. D. Gill, “Cox's regression model for counting processes: A large sample study,”Amer. Stat. vol. 12 pp. 730–736, 1982.

    Google Scholar 

  • J. R. Anderson, K. C. Cain, and R. D. Gelber, “Analysis of survival by tumor response,”J. Clin. Oncol. vol. 1 pp. 710–719, 1983.

    Google Scholar 

  • J. Crowley and M. Hu, “Covariance analysis of heart transplant survival data,”J. Am. Stat. Assoc. vol. 72 pp. 27–35, 1977.

    Google Scholar 

  • Robert J. Gray, “A kernel method for incorporating information on disease progression in the analysis of survival,”Biometrika vol. 81 pp. 527–539, 1994.

    Google Scholar 

  • F. Y. Hsieh, J. Crowley, and D. C. Tormey, “Some test statistics for use in multistate survival analysis,”Biometrika vol. 70 pp. 111–119, 1983.

    Google Scholar 

  • N. Mantel and D. P. Byar, “Evaluation of response-time data involving transient states: An illustration using heart-transplant data,”J. Am. Stat. Assoc. vol. 69 pp. 81–86, 1974.

    Google Scholar 

  • B. W. Turnbull, B. W. Brown, and M. Hu, “Survivorship analysis of heart transplant data,”J. Am. Stat. Assoc. vol. 69 pp. 74–80, 1974.

    Google Scholar 

  • G. H. Weiss and M. Zelen, “A stochastic model for the interpretation of clinical trials,”Proc. Natl. Acad. Sci. vol. 50 pp. 988–994, 1963.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Deceased

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lefkopoulou, M., Zelen, M. Intermediate clinical events, surrogate markers and survival. Lifetime Data Anal 1, 73–85 (1995). https://doi.org/10.1007/BF00985259

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00985259

Keywords

Navigation